Skip to content

CHRN · available-data snapshot

ChronoScale Holdings Corporation (CHRN): Available-Data Snapshot

TickerWorth does not publish a DCF fair value for ChronoScale Holdings Corporation (CHRN); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.

Model by · generated from public market data · Updated Oct 19, 2026 · How these pages are made

Why is there no fair value for CHRN?

We do not publish a fair value for ChronoScale Holdings Corporation. What we can say from its filings and market data is below.

What is CHRN's TickerWorth Score?

F15/100

Scores lower than almost every company we compare it with

Compared with Technology companies in US

Its strongest point: recent price trend has been strong. Its weakest: profitability is weak.

  • Value · 14 of 100

    Cheaper than 14% of Technology companies in US

  • Price vs worth · 0 of 100
  • Quality · 4 of 100

    More profitable than 4% of Technology companies in US

  • Financial health · 15 of 100

    Financially stronger than 15% of Technology companies in US

  • Growth · — of 100
  • Momentum · 64 of 100

    Outperformed 64% of Technology companies in US over the past year

Confidence: Medium confidence · Scored

Get the Undervalued Company of the Week.

The Weekly Undervalued

The Undervalued Company of the Week, with its fair-value range and the growth its price implies. We'll email you when the weekly list starts. Not advice or trading calls.

Price
$15.46
Market cap
$2,245,021,184
52-week high
$30.00
52-week low
$3.50
Currency
USD
Exchange
NasdaqCM

Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.

What we can say

We don't publish a discounted-cash-flow fair value for ChronoScale Holdings Corporation (CHRN) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.

Read the full reasoning

On the numbers we do have, CHRN trades at a recent price of $15.46, a market capitalisation of about $2,245,021,184, sitting 45% of the way up its 52-week range ($3.50–$30.00), on the NasdaqCM.

The standard alternative to a DCF is relative valuation — comparing CHRN's trading multiples against a sector benchmark. Here that gives Fwd P/E of 88.3× (richer than the peer median of 17.3×); P/B of 12.5× (cheaper than the peer median of 16.1×); P/S of 31.4× (richer than the peer median of 11.9×); EV/EBITDA of 86.8× (richer than the peer median of 25.5×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. CHRN shows a price-to-book (P/B) of 12.47 and book value of $1.24 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. CHRN is in a mixed trend, trading -48.5% from its 52-week high. Over the past year the stock is +211.6%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

CHRN vs peers

Sector benchmark (bellwethers, not direct competitors).

MultipleCHRNPeer medianRead
Fwd P/E88.3×17.3×richer than
P/B12.5×16.1×cheaper than
P/S31.4×11.9×richer than
EV/EBITDA86.8×25.5×richer than

What does ChronoScale Holdings Corporation do?

What does it do?

ChronoScale Holdings Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads in the United States. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. It operates in the Information Technology Services industry (Technology sector), headquartered in United States. The company employs roughly 84 people.

How does it make money?

The business turns $72M in annual revenue into profit. Out of every $100 of sales, about $0 is left as operating profit (operating margin of -47.1%), after a -24% gross margin on the products/services it sells. After all costs, taxes and interest, -70.3% of revenue becomes bottom-line net profit.

Is it financially healthy?

Financially it looks stretched: carries modest debt (0.7× equity), may struggle to cover its short-term bills (0.5× current ratio), and is currently lossmaking.

Who at CHRN filed insider trades?

Recent insider filings for ChronoScale Holdings Corporation
DateInsiderRelationshipWhat happenedValueFiling
Davis Scott G.DirectorGrant / award—Form 4 for Davis Scott G. (opens sec.gov in a new tab)
Wong JeromeChief Financial OfficerGrant / award—Form 4 for Wong Jerome (opens sec.gov in a new tab)
Jegannathan RajasekarChief Technology OfficerGrant / award—Form 4 for Jegannathan Rajasekar (opens sec.gov in a new tab)
Chen Ying CenlyDirector, Chief Executive OfficerGrant / award—Form 4 for Chen Ying Cenly (opens sec.gov in a new tab)
Schaap Andrew CordellDirectorGrant / award—Form 4 for Schaap Andrew Cordell (opens sec.gov in a new tab)
CLANCY WILLIAM MDirectorGrant / award—Form 4 for CLANCY WILLIAM M (opens sec.gov in a new tab)

A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans

Not investment advice. TickerWorth Score is a model output.

A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.